Discovery of 4-((2 <i>S</i> ,4 <i>S</i> )-4-Ethoxy-1-((5-methoxy-7-methyl-1 <i>H</i> -indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated DiseasesNello Mainolfi, Christopher M. Adams, Takeru Ehara et al.|Journal of Medicinal Chemistry|2020Cited by 61
Characterization of muscarinic receptors mediating vasodilation in guinea-pig ileum submucosal arterioles by the use of computer-assisted videomicroscopyEdwin Bungardt, Annmarie Surprenant, Günter Lambrecht et al.|European Journal of Pharmacology|1992Cited by 22
Complement factor B in complex with (S)-5,7-Dimethyl-4-((2-phenylpiperidin-1-yl)methyl)-1H-indoleNello Mainolfi, Bruce Jaffee, Takashi Ehara et al.|Unknown|2019Cited by 0